通过序贯动脉灌注选择重度雷诺现象的血管扩张剂治疗。
Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.
作者信息
Russell I J, Walsh R A
出版信息
Ann Rheum Dis. 1985 Mar;44(3):151-4. doi: 10.1136/ard.44.3.151.
Abstract
Two young adults with impending gangrene due to persistent Raynaud's vasospasm were studied by sequential intra-arterial (IA) infusion of three vasodilatory drugs while arterial pressure and plethysmographic digital pulse volume were continuously monitored. The results of the IA infusion accurately predicted relief from vasospastic symptoms by oral drugs of the same class. This method may be useful in selecting the most effective vasodilator for patients with severe vasospasm.
摘要
对两名因持续性雷诺血管痉挛而濒临坏疽的年轻成年人进行了研究，通过依次动脉内（IA）输注三种血管扩张药物，同时持续监测动脉压和体积描记法测量的数字脉搏容积。IA输注的结果准确预测了同一类口服药物对血管痉挛症状的缓解情况。这种方法可能有助于为严重血管痉挛患者选择最有效的血管扩张剂。
相似文献
1
Selection of vasodilator therapy for severe Raynaud's phenomenon by sequential arterial infusion.通过序贯动脉灌注选择重度雷诺现象的血管扩张剂治疗。
Ann Rheum Dis. 1985 Mar;44(3):151-4. doi: 10.1136/ard.44.3.151.
2
3
A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.四烟酰果糖（布拉地兰）对原发性和继发性雷诺现象中手指血流影响的体积描记法研究
Angiology. 1974 May;25(5):312-6. doi: 10.1177/000331977402500503.
4
Pharmacotherapy of Raynaud's phenomenon.雷诺现象的药物治疗。
Drugs. 1996 Nov;52(5):682-95. doi: 10.2165/00003495-199652050-00006.
5
The diagnosis and treatment of Raynaud's phenomenon.雷诺现象的诊断与治疗。
Surgery. 1975 Jan;77(1):11-23.
6
Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.雷诺现象中增强的胆碱能性皮肤血管舒张。
Circulation. 1994 Mar;89(3):1183-8. doi: 10.1161/01.cir.89.3.1183.
7
Role of digital artery adrenoceptors in Raynaud's disease.数字动脉肾上腺素能受体在雷诺病中的作用。
Vasc Med. 1997;2(1):1-7. doi: 10.1177/1358863X9700200101.
8
Limb-threatening lower extremity ischemia successfully treated with intra-arterial infusion--case reports.经动脉内灌注成功治疗威胁肢体的下肢缺血——病例报告
Angiology. 1999 Mar;50(3):233-7. doi: 10.1177/000331979905000308.
9
Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.西地那非治疗对血管扩张疗法耐药的雷诺现象。
Circulation. 2005 Nov 8;112(19):2980-5. doi: 10.1161/CIRCULATIONAHA.104.523324.
10
Raynaud's phenomenon (primary).雷诺现象（原发性）
Clin Evid. 2003 Jun(9):1339-48.
本文引用的文献
1
Oral hydralazine therapy for primary pulmonary hypertension.口服肼苯哒嗪治疗原发性肺动脉高压。
N Engl J Med. 1980 Jan 10;302(2):69-73. doi: 10.1056/NEJM198001103020201.
2
Vasodilator therapy of pulmonary hypertension in the CRST syndrome.CRST综合征中肺动脉高压的血管扩张剂治疗
Ir J Med Sci. 1982 May;151(5):151-4. doi: 10.1007/BF02940166.
3
Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.硝苯地平治疗雷诺现象的对照试验。
Lancet. 1982 Dec 11;2(8311):1299-301. doi: 10.1016/s0140-6736(82)91508-2.
4
Drug therapy. Hydralazine.药物治疗。肼屈嗪。
N Engl J Med. 1976 Aug 5;295(6):320-3. doi: 10.1056/NEJM197608052950606.
5
Pathophysiology of Raynaud's disease.雷诺病的病理生理学
Arch Intern Med. 1979 Jan;139(1):89-92.
6
A maneuver to reverse Raynaud's phenomenon of the fingers.一种逆转手指雷诺现象的手法。
JAMA. 1978 Dec 15;240(25):2760.
Zotero 插件